CooperSurgical buys to expand cervical cancer line
This article was originally published in Clinica
Executive Summary
The Cooper Companies women's health division, CooperSurgical, continues its strategy of deals involving smaller companies or product lines with the purchase of Swedish company Medscand Medical and an affiliated US company, Medscand (USA), for $12 million. The company develops and manufactures specimen collection products for cervical cancer and has supply deals with Cytyc and Digene.